EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016–2020

Tess Stopczynski iD, Justin Z Amarin, James W Antoon, Olla Hamdan iD, Laura S Stewart, James Chappell, Andrew J Spieker, Eileen J Klein, Janet A Englund iD, Geoffrey A Weinberg, Peter G Szilagyi, John V Williams und 13 weitere

Influenza and Other Respiratory Viruses · 2025

DOI: 10.1111/irv.70124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2025. Verfasst von Tess Stopczynski und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Influenza, Human, Emergency Service, Hospital, Antiviral Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCIRD CDC HHS, CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Influenza contributes to a high burden of pediatric emergency department (ED) visits annually. Guidelines recommend outpatient antiviral treatment for children at higher risk of severe influenza and recommend considering treatment for those who present within 2 days of symptom onset. We describe antiviral prescription in children with influenza presenting to the ED.

Methods

We analyzed data from the New Vaccine Surveillance Network (2016–2020), including children presenting to the ED and enrolled with confirmed influenza at one of seven pediatric academic centers. We compared characteristics of children prescribed antivirals to those who were not, using generalized estimating equations models to identify predictors of antiviral prescription. Children were considered at higher risk of severe influenza if they were < 5 years old or had an underlying condition.

Results

Overall, 2472 (15%) of 16,915 enrolled children tested positive for influenza virus. Among these, 1931 (78%) were at higher risk of severe influenza; only 622 (32%) received an antiviral. Among 233 (9%) children not at high risk with symptom onset ≤ 2 days, 62 (27%) were prescribed an antiviral. Children prescribed an antiviral had a shorter duration of illness prior to presenting to the ED. For children at higher risk of severe influenza, odds of antiviral prescription were higher for those clinically tested for influenza and with underlying conditions.

Conclusion

Clinical testing and having an underlying condition were associated with antiviral prescription in children at higher risk of severe influenza. However, only 1/3 of those at higher risk were prescribed an antiviral. Strategies to increase antiviral use for children at higher risk for influenza in the ED are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanEmergency Service, HospitalAntiviral AgentsHumansChild, PreschoolMaleFemaleInfantChildUnited StatesAdolescentInfluenza VaccinesInfant, Newborn

Stichwörter der Autor:innen

antiviralsinfluenzapediatrics

Substanzen

Antiviral AgentsInfluenza Vaccines

Autor:innen und Institutionen

  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Seattle Children's Research Institute, Seattle, Washington, USA.
  • University of Rochester School of Medicine and Dentistry & UR-Golisano Children's Hospital, Rochester, New York, USA.
  • University of California at Los Angeles (UCLA), Los Angeles, CA, USA.
  • Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

ORCID-Profile: Tess Stopczynski, Olla Hamdan, Janet A Englund, Christopher J Harrison, Samantha M Olson

Förderung

  • NIAID NIH HHS
  • NCIRD CDC HHS
  • CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Stopczynski, T., Amarin, J. Z., Antoon, J. W., Hamdan, O., Stewart, L. S., Chappell, J., Spieker, A. J., Klein, E. J., Englund, J. A., Weinberg, G. A., Szilagyi, P. G., Williams, J. V., Michaels, M. G., Boom, J. A., Sahni, L. C., Staat, M. A., Schlaudecker, E. P., Schuster, J. E., Selvarangan, R., …, & Halasa, N. B. (2025). Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016–2020. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70124

Vancouver

Stopczynski T, Amarin JZ, Antoon JW, Hamdan O, Stewart LS, Chappell J, et al. Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016–2020. Influenza and Other Respiratory Viruses. 2025. doi:10.1111/irv.70124

BibTeX
@article{Stopczynski2025,
  author = {Stopczynski, Tess and Amarin, Justin Z and Antoon, James W and Hamdan, Olla and Stewart, Laura S and Chappell, James and Spieker, Andrew J and Klein, Eileen J and Englund, Janet A and Weinberg, Geoffrey A and Szilagyi, Peter G and Williams, John V and Michaels, Marian G and Boom, Julie A and Sahni, Leila C and Staat, Mary Allen and Schlaudecker, Elizabeth P and Schuster, Jennifer E and Selvarangan, Rangaraj and Harrison, Christopher J and Moline, Heidi L and Toepfer, Ariana P and Campbell, Angela P and Olson, Samantha M and Halasa, Natasha B},
  title = {Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016–2020},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2025},
  doi = {10.1111/irv.70124}
}
Kostenlos starten →